ADVFN US – Market Content Editor
-

Strategy Expands Bitcoin Holdings Following Preferred Stock Offering
MicroStrategy Incorporated, which trades as Strategy (NASDAQ:MSTR), disclosed in a Form 8-K that it increased its bitcoin reserves between August 4 and August 10, 2025, using proceeds from recent preferred stock sales. During the period, the company sold 115,169 shares of its 10.00% Series A Perpetual Strife Preferred Stock (STRF), raising $11.5 million in face…
-

Micron Shares Climb on Upgraded Q4 Forecast
Micron Technology (NASDAQ:MU) saw its stock jump 5.6% in pre-market trading Monday after the memory chipmaker raised its fiscal fourth-quarter 2025 outlook, pointing to stronger pricing and solid operational performance. The Idaho-based company now expects quarterly revenue between $11.1 billion and $11.3 billion, with a midpoint of $11.2 billion. That’s up from its prior range…
-

Weekly Market Outlook: Dow Jones, Nasdaq, S&P 500 Investors Eye CPI Report Amid Strong Tech Rally
U.S. equities closed out the week with solid gains on Friday, led by the technology sector’s impressive performance. The Nasdaq Composite surged 0.98% to a new record high of 21,450.02 after reaching an intraday peak earlier in the session. The S&P 500 rose 0.78% to 6,389.45, just below its all-time closing high, while the Dow…
-

AMC Entertainment shares surge nearly 6% after Q2 results top forecasts
AMC Entertainment Holdings, Inc. (NYSE:AMC) reported stronger-than-anticipated second-quarter results on Monday, posting breakeven earnings per share compared to analyst expectations of a loss. Following the announcement, the company’s shares climbed 5.80% in pre-market trading. The world’s largest movie theater operator recorded earnings per share of $0.00 for the quarter, well ahead of the predicted -$0.09.…
-

Excelerate Energy surpasses Q2 forecasts and lifts guidance
On Monday, Excelerate Energy, Inc. (NYSE:EE) announced adjusted earnings of $0.34 per share for the second quarter, beating analyst estimates of $0.29, despite reporting revenue of $204.6 million, which fell short of the $243.2 million consensus. Following the news, the company’s shares climbed 0.74% in pre-market trading. The LNG infrastructure provider posted adjusted EBITDA of…
-

Owens & Minor falls short of Q2 earnings forecasts amid divestiture plans
On Monday, Owens & Minor Inc. (NYSE:OMI) reported adjusted earnings for the second quarter that missed analyst projections as the healthcare services firm advances its plan to sell off its Products & Healthcare Services (NASDAQ:HCSG) division. Following the announcement, the company’s shares dropped 1.83% in after-hours trading. Adjusted earnings per share for Q2 came in…
-

Barrick Mining shares fall as revenue misses forecasts despite operational gains
Shares of Barrick Mining Corporation (NYSE:B) dropped 4.4% following the release of its second-quarter results, as revenue came in below analyst expectations despite growth in production and cash flow. The company reported Q2 revenue of $3.68 billion, missing the consensus estimate of $3.73 billion. However, earnings per share reached $0.47, beating the anticipated $0.44. Gold…
-

Franco-Nevada shares drop nearly 5% as revenue falls short despite record earnings
On Monday, Franco-Nevada Corporation (NYSE:FNV) revealed second-quarter revenue that failed to meet analyst forecasts, even though the company posted record earnings and cash flow supported by rising gold prices. Following the announcement, shares fell 4.71% in pre-market trading. The company reported Q2 revenue of $369.4 million, slightly below the consensus estimate of $375.91 million, but…
-

Dole shares climb after Q2 earnings surpass expectations amid robust produce demand
Dole plc (NYSE:DOLE) reported better-than-expected second-quarter earnings on Thursday, fueled by strong results across all continuing business segments. Following the announcement, the company’s shares gained 2.05%. For the quarter ended June 30, 2025, Dole posted adjusted earnings per share of $0.55, topping analyst forecasts of $0.51. Revenue reached $2.4 billion, well above the anticipated $2.16…
-

GSK shares rise after FDA grants priority review for oral gonorrhea antibiotic
GSK (NYSE:GSK) announced Monday that the U.S. Food and Drug Administration has accepted its priority review application for gepotidacin, an oral antibiotic designed to treat uncomplicated sexually transmitted gonorrhea. Following the news, GSK’s shares edged up 1% in London trading. The pharmaceutical company is focusing on new infectious disease treatments, including its recently introduced respiratory…